IP Verse

Exelixis, Inc. V. Cipla Ltd. - 1:24-cv-00565

Explore the details of the Exelixis, Inc. V. Cipla Ltd. case under case number 1:24-cv-00565 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00565
Filing Date
May 9, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Exelixis, Inc. -
Cipla Ltd. -

Patents Involved in the Case

This case involves 5 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11098015B2
-US8877776B2
-US11298349B2
-US11091440B2
-US11091439B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

May 9, 2024Summonses Issued (please complete the top portion of the form and print out for use/service). (mpb) (Entered: 05/09/2024)PACER Document
May 9, 2024Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc.. (mpb) (Entered: 05/09/2024)PACER Document
May 9, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2 ; 11,298,349 B2. (mpb) (Entered: 05/09/2024)PACER Document
May 9, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/28/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/28/2026. (mpb) Modified on 5/23/2024 (mpb). (Entered: 05/09/2024)PACER Document
May 9, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 05/09/2024)PACER Document
May 9, 2024COMPLAINT filed against Cipla Ltd., Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4403682.) - filed by Exelixis, Inc.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(mpb) (Entered: 05/09/2024)PACER Document
May 28, 2024WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla USA, Inc. waiver sent on 5/22/2024, answer due 7/22/2024. (Raucci, Anthony) (Entered: 05/28/2024)PACER Document
May 28, 2024WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla Ltd. waiver sent on 5/22/2024, answer due 7/22/2024. (Raucci, Anthony) (Entered: 05/28/2024)PACER Document
Jun 13, 2024NOTICE requesting Clerk to remove Kevin M. Yurkerwich as co-counsel.. (Raucci, Anthony) (Entered: 06/13/2024)PACER Document
May 15, 2024Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms)PACER Document
May 23, 2024CORRECTING ENTRY: Docket text of D.I. 3 has been modified to reflect the correct date Patentee(s) received notice. (mpb)PACER Document
Jul 8, 2024STIPULATION of Dismissal Without Prejudice, by Exelixis, Inc.. (Raucci, Anthony) Modified on 7/9/2024 (nms). (Entered: 07/08/2024)PACER Document
Jul 9, 2024SO ORDERED Granting (D.I. 15 in 23-cv-287-RGA; D.I. 10 in 24-cv-565-RGA) Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/9/2024. Associated Cases: 1:24-cv-00565-RGA, 1:23-cv-00287-RGA(nms) (Entered: 07/09/2024)PACER Document
Jul 10, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2; 11,298,349 B2. (Attachments: # 1 Order)(nms) (Entered: 07/10/2024)PACER Document